JAK inhibitor XL019, Purity ≥98%

Synonym: XL019; 945755-56-6; (S)-N-(4-(2-((4-Morpholinophenyl)amino)pyrimidin-4-yl)phenyl)pyrrolidine-2-carboxamide; XL-019; 4L1AM42NVA; (2S)-N-[4-[2-[[4-(4-Morpholinyl)phenyl]amino]-4-pyrimidinyl]phenyl]-2-pyrrolidinecarboxamide; (2S)-N-[4-(2-{[4-(MORPHOLIN-4-YL)PHENYL]AMINO}PYRIMIDIN-4-YL)PHENYL]PYRROLIDINE-2-CARBOXAMIDE; JAK inhibitor

MDL: MFCD24386874
CAS Number: 945755-56-6
Compound CID: 57990869

Product Size

5 mg; 10 mg; 25 mg; 50 mg; 100 mg

Price

Datasheet

MSDS

Properties

Description

XL019, soluble in DMSO and insoluble in ethanol and water, is an available JAK small molecule inhibitor with potential antineoplastic activity.

Molecular Weight

444.53

Molecular Formula

C₂₅H₂₈N₆O₂

Form

Lyophilized powder

Purity

Solubility

DMSO: 14 mg/mL (31.49 mM); Water: Insoluble; Ethanol: Insoluble

Identity

Confirmed by NMR/HPLC/MS.

Applications

XL019 can be employed to study JAK2 inhibition in hematologic malignancies.